Bioxyne (BXN.AX) Earnings Analysis
Bioxyne (BXN.AX) has no confirmed upcoming earnings date. Trailing P/E 23.25.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BXN.AX next report earnings?
No confirmed upcoming earnings date is currently scheduled for BXN.AX. This page updates as the calendar is published.
BXN.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | 0.033 AUD | n/a | n/a | n/a |
| 2025-07-27 | 0.007 AUD | n/a | n/a | n/a |
| 2025-02-28 | 0.016 AUD | n/a | n/a | n/a |
| 2024-10-16 | -0.005 AUD | n/a | n/a | n/a |
| 2024-08-30 | -0.065 AUD | n/a | n/a | n/a |
BXN.AX valuation and analyst view
| Trailing P/E | 23.25 |
|---|---|
| Trailing EPS | 0.04029 AUD |
| Price / book | 10.26 |
| Dividend yield | 0.00% |
| Market cap | 0.21B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Bioxyne (BXN.AX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for BXN.AX. This page updates as the calendar is published.
Did BXN.AX beat earnings last quarter?
Consensus estimate data was not available for BXN.AX's 2026-02-26 report.
What is BXN.AX's current P/E ratio and EPS?
BXN.AX trades at a trailing P/E of 23.25 on trailing EPS of 0.04028571159859161 AUD.
What do analysts rate BXN.AX?
BXN.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.